197 related articles for article (PubMed ID: 35449086)
1. Cross talk between RNA modification writers and tumor development as a basis for guiding personalized therapy of gastric cancer.
Zhang S; Kuang G; Huang Y; Huang X; Wang W; Wang G
Hum Genomics; 2022 Apr; 16(1):14. PubMed ID: 35449086
[TBL] [Abstract][Full Text] [Related]
2. Cross-talk of four types of RNA modification writers defines tumor microenvironment and pharmacogenomic landscape in colorectal cancer.
Chen H; Yao J; Bao R; Dong Y; Zhang T; Du Y; Wang G; Ni D; Xun Z; Niu X; Ye Y; Li HB
Mol Cancer; 2021 Feb; 20(1):29. PubMed ID: 33557837
[TBL] [Abstract][Full Text] [Related]
3. Cross-talk of RNA modification "writers" describes tumor stemness and microenvironment and guides personalized immunotherapy for gastric cancer.
Li Z; Zhang X; Weng W; Zhang G; Ren Q; Tian Y
Aging (Albany NY); 2023 Jun; 15(12):5445-5481. PubMed ID: 37319315
[TBL] [Abstract][Full Text] [Related]
4. RNA modification writers influence tumor microenvironment in gastric cancer and prospects of targeted drug therapy.
Song P; Zhou S; Qi X; Jiao Y; Gong Y; Zhao J; Yang H; Qian Z; Qian J; Tang L
J Bioinform Comput Biol; 2022 Apr; 20(2):2250004. PubMed ID: 35287562
[No Abstract] [Full Text] [Related]
5. A novel scoring model based on RNA modification "writers" can predict the prognosis and guide immunotherapy in gastric cancer.
Li X; Zhou Y; Jiang Q; Huang J; Liu Z; Li Y; Guo G
Funct Integr Genomics; 2023 May; 23(2):162. PubMed ID: 37188931
[TBL] [Abstract][Full Text] [Related]
6. Interplay of four types of RNA modification writers revealed distinct tumor microenvironment and biological characteristics in pancreatic cancer.
Gao W; Chen D; Liu J; Zang L; Xiao T; Zhang X; Li Z; Zhu H; Yu X
Front Immunol; 2022; 13():1031184. PubMed ID: 36601127
[TBL] [Abstract][Full Text] [Related]
7. RNA modification "writer"-mediated RNA modification patterns and tumor microenvironment characteristics of cervical cancer.
Qu Y; Zhu H; Kong C; Zheng X; Wang D; Chen X; Yuan D
Clin Transl Oncol; 2022 Jul; 24(7):1413-1424. PubMed ID: 35220552
[TBL] [Abstract][Full Text] [Related]
8. Expression profiles and prognostic roles of m6A writers, erasers and readers in gastric cancer.
Jing JJ; Zhao X; Li H; Sun LP; Yuan Y
Future Oncol; 2021 Jul; 17(20):2605-2620. PubMed ID: 33878934
[TBL] [Abstract][Full Text] [Related]
9. Integrated investigation of the clinical implications and targeted landscape for RNA methylation modifications in hepatocellular carcinoma.
Zhang J; Gao J; Hu M; Xu S; Cheng C; Zheng W; Zhang J
Eur J Med Res; 2023 Jan; 28(1):46. PubMed ID: 36707911
[TBL] [Abstract][Full Text] [Related]
10. A new risk model based on a 11-m
Lei L; Li N; Yuan P; Liu D
BMC Cancer; 2022 Apr; 22(1):365. PubMed ID: 35382776
[TBL] [Abstract][Full Text] [Related]
11. Crosstalk of RNA Adenosine Modification-Related Subtypes, Establishment of a Prognostic Model, and Immune Infiltration Characteristics in Ovarian Cancer.
Ni X; Chen C; Cui G; Ding W; Liu J
Front Immunol; 2022; 13():932876. PubMed ID: 35837397
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk Between Four Types of RNA Modification Writers Characterizes the Tumor Immune Microenvironment Infiltration Patterns in Skin Cutaneous Melanoma.
Zhang S; Xiong Y; Zheng C; Long J; Zhou H; Zeng Z; Ouyang Y; Tang F
Front Cell Dev Biol; 2022; 10():821678. PubMed ID: 35155433
[TBL] [Abstract][Full Text] [Related]
13. Reduced m6A modification predicts malignant phenotypes and augmented Wnt/PI3K-Akt signaling in gastric cancer.
Zhang C; Zhang M; Ge S; Huang W; Lin X; Gao J; Gong J; Shen L
Cancer Med; 2019 Aug; 8(10):4766-4781. PubMed ID: 31243897
[TBL] [Abstract][Full Text] [Related]
14. m
Zhang B; Wu Q; Li B; Wang D; Wang L; Zhou YL
Mol Cancer; 2020 Mar; 19(1):53. PubMed ID: 32164750
[TBL] [Abstract][Full Text] [Related]
15. RNA m
Zhang Q; Sun X; Sun J; Lu J; Gao X; Shen K; Qin X
Front Immunol; 2022; 13():905057. PubMed ID: 36389669
[TBL] [Abstract][Full Text] [Related]
16. Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer.
Song J; Wei R; Huo S; Gao J; Liu X
Front Immunol; 2022; 13():920512. PubMed ID: 35769483
[TBL] [Abstract][Full Text] [Related]
17. The Identification of Two RNA Modification Patterns and Tumor Microenvironment Infiltration Characterization of Lung Adenocarcinoma.
He W; Lin G; Pan C; Li W; Shen J; Liu Y; Li H; Wu D; Lin X
Front Genet; 2022; 13():761681. PubMed ID: 35154267
[No Abstract] [Full Text] [Related]
18. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
19. Immune infiltration profiling in gastric cancer and their clinical implications.
Ren F; Zhao Q; Zhao M; Zhu S; Liu B; Bukhari I; Zhang K; Wu W; Fu Y; Yu Y; Tang Y; Zheng P; Mi Y
Cancer Sci; 2021 Sep; 112(9):3569-3584. PubMed ID: 34251747
[TBL] [Abstract][Full Text] [Related]
20. RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer.
Zhou B; Bie F; Zang R; Zhang M; Song P; Liu L; Peng Y; Bai G; Zhao J; Gao S
EBioMedicine; 2022 Oct; 84():104268. PubMed ID: 36116215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
